Perspective
Published on 20 Dec 2022
An approach to data collection in compassionate use/managed access
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1095860
- 6,266 views
- 7 citations
Type at least 3 characters
2,010 articles
Articles
Editorial
Published on 20 Dec 2022
Editorial: Drug repurposing and polypharmacology: A synergistic approach in multi-target based drug discovery
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1101007
- 2,920 views
- 7 citations
General Commentary
Published on 20 Dec 2022
Commentary: Tailored therapy for Helicobacter pylori eradication: A systematic review and meta-analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1090776
- 1,822 views
Original Research
Published on 16 Dec 2022
Evaluating the benefits of TNF-alfa inhibitor biosimilar competition on off-patent and on-patent drug markets: A Southern European analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1031910
- 3,697 views
- 4 citations
Systematic Review
Published on 16 Dec 2022
Prevalence of polypharmacy and potentially inappropriate medication use in older lung cancer patients: A systematic review and meta-analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1044885
- 3,469 views
- 7 citations
Original Research
Published on 15 Dec 2022
Pharmacovigilance of triazole antifungal agents: Analysis of the FDA adverse event reporting system (FAERS) database
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1039867
- 7,278 views
- 12 citations
Original Research
Published on 15 Dec 2022
Perceptions of healthcare professionals and patients on the role of the pharmacist in TB management in Pakistan: A qualitative study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.965806
- 5,671 views
- 365 citations
Policy Brief
Published on 13 Dec 2022
Bring the life stages into the domain of basic and clinical pharmacology
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.923016
- 2,480 views
- 5 citations
Original Research
Published on 13 Dec 2022
Pharmacist-led olaparib follow-up service for ambulatory ovarian cancer patients: A prospective study in a tertiary specialized cancer hospital in China
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1037726
- 2,073 views
- 1 citation
Systematic Review
Published on 13 Dec 2022
Cost-effectiveness of janus kinase inhibitors for rheumatoid arthritis: A systematic review and meta-analysis of cost-utility studies
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1090361
- 4,325 views
- 7 citations
Original Research
Published on 12 Dec 2022
Association between different concentrations of human serum albumin and 28-day mortality in intensive care patients with sepsis: A propensity score matching analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1037893
- 2,670 views
- 2 citations
Original Research
Published on 12 Dec 2022
Evaluation of short-term intraocular pressure changes after intravitreal injection of Conbercept in patients with diabetic macular edema
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1025205
- 1,549 views
- 3 citations
Systematic Review
Published on 12 Dec 2022
Efficacy and safety evaluation of dexmedetomidine for postoperative patient controlled intravenous analgesia: A systematic review and meta-analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1028704
- 3,015 views
- 6 citations
Original Research
Published on 09 Dec 2022
Safety of oral nemonoxacin: A systematic review of clinical trials and postmarketing surveillance
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1067686
- 2,981 views
Methods
Published on 07 Dec 2022
Development and validation of a new non-disease-specific survey tool to assess self-reported adherence to medication
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.981368
- 3,594 views
- 4 citations
Original Research
Published on 07 Dec 2022
First-line sintilimab plus chemotherapy in locally advanced or metastatic esophageal squamous cell carcinoma: A cost-effectiveness analysis from China
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.967182
- 2,347 views
- 15 citations